Skip to content
Angle logo
  • About us
    • Discover ANGLE
    • Our team
    • Careers
    • Events
    • News
    • Corporate social responsibility
  • Technology
    • Parsortix® technology
    • Parsortix PC1 system – clinical
    • Parsortix PR1 system – research
  • Product solutions
    • Discover all Product solutions
    • Systems:
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
    • Downstream analysis:
      • Portrait+ CTC Staining Kit
  • Laboratory services
    • Discover all Laboratory services
    • Immunofluorescence:
      • Enumeration
      • Portrait®Flex
      • DNA damage response (DDR)
      • Portrait®PD-L1
      • Custom CTC assays
      • HER2
  • Resources
    • View all resources
      • Publications
      • Posters
      • Articles
      • Whitepapers
      • Presentations
    • Translational research
      • Breast cancer
      • Prostate cancer
      • Ovarian cancer
    • Instructions for Use documents
    • Product information
  • Contact us
  • Investors
Investors
  • Business strategy
  • Market size
  • Regulatory news
  • Share price
  • Financial reports
  • Financial Calendar
  • Corporate responsibility report
  • Glossary
  • Email alerts
AIM Rule 26
  • Corporate governance
  • Significant shareholders
  • ADR
  • Advisors
Corporate presentations
  • ANGLE in the media
  • Analyst research

Latest report

Annual Report December 2023

Please click the links below to download our Annual and Interim Reports and Financial Statements

Open PDF

For any investor relations queries please contact

investor@angleplc.com
  • About Us
    • Discover ANGLE
    • Our team
    • Careers
    • Events
    • Corporate social responsibility
  • Technology
    • Parsortix®technology
    • Parsortix PC1 system – clinical
    • Parsortix PR1 system – research
  • Product solutions
    • Discover all Product solutions
    • Systems:
      • Portrait+ CTC staining kit
    • Downstream analysis:
      • Parsortix PC1 system – clinical
      • Parsortix PR1 system – research
  • Laboratory services
    • Discover all Laboratory services
    • Immunofluorescence:
      • CTC enumeration
      • Portrait®Flex
      • DNA damage response (DDR)
      • Portrait®PD-L1
      • Custom CTC assays
      • HER2
  • Resources
    • Discover all Resources
    • Publications
    • Translational research
    • Instructions for Use documents
    • Product information
  • Contact us
  • Investors
    • Investors
      • Business strategy
      • Market size
      • Regulatory news
      • Share price
      • Financial reports
      • Financial Calendar
      • Corporate responsibility report
      • Glossary
      • Email alerts
    • AIM 26
      • Corporate governance
      • Significant shareholders
      • ADR
      • Advisors
    • Corporate presentations
      • ANGLE in the media
      • Analyst research

For any investor relations queries please contact

investor@angleplc.com

New publication!

Posted on January 22, 2024June 5, 2024 by Sangeetha Dhandapani

Complementary insights from a single blood sample utilising the Parsortix® system.

  • About us
  • Technology
  • Product solutions
  • Laboratory services
  • Resources
  • Investors
  • Contact us
2 Occam Court, Occam Road, Surrey Research Park, Guildford, GU2 7QB, UK +44 (0)1483 343434
5100 Campus Drive, Suite 120, Plymouth Meeting, PA 19462, USA +1 610 233 4712
10 Nugent Road, Surrey Research Park, Guildford, GU2 7AF, UK
© ANGLE plc 2024
  • Privacy policy
  • Cookies declaration
  • Terms & conditions